SEC Form 4 · accession 0001209191-19-007576
PROTEOSTASIS THERAPEUTICS, INC. · PTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marija Zecevic
Officer — Chief Operating Officer
Period of report
Feb 1, 2019
Accepted (ET)
Feb 5, 2019 · 8:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001445283
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 1, 2019 | M | 22,313 | — | A | 22,313 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Feb 1, 2019 | M | 22,313 | D | — | — | Common Stock | 22,313 | 0 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of PTI common stock.
- F2The restricted stock units vested in full on February 1, 2019.